RxDoctor Payments Data

Laura Willoughby

Psychiatric/Mental Health · Saint Joseph, MONPI 1639418262

Payments from drug & device makers

$2,295in general payments, 2019–2025

Across 138 payments — averaging $16.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$402
  • Sunovion Pharmaceuticals Inc.$376
  • Vanda Pharmaceuticals Inc.$293
  • Teva Pharmaceuticals USA, Inc.$260
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$225
  • Alkermes, Inc.$176
  • plus $564 from 8 others

What the payments were for

  • Food & beverage$2,295100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,295 in reported general payments places this provider in the 70th percentile of 565 psychiatric/mental health providers in Missouri.

See all psychiatric/mental health providers in Missouri

Medicare billing

Part B allowed, 2024
$9,090
Medicare patients
36
Services billed
151

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine28$197,453
RexultiBrexpiprazole60$105,907
VraylarCariprazine Hcl64$96,577
Invega SustennaPaliperidone Palmitate13$49,743
Aripiprazole98$25,873
Lurasidone Hcl24$13,962
Paliperidone ErPaliperidone29$5,286
Olanzapine47$5,130
Ziprasidone Hcl37$4,675
Naltrexone Hcl25$3,660
Quetiapine Fumarate113$3,320
Fluvoxamine Maleate53$3,261
Gabapentin105$2,678
Bupropion XlBupropion Hcl76$2,538
Quetiapine Fumarate ErQuetiapine Fumarate12$2,512

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo, Loxapine$260$197,91044 claims
Otsuka America Pharmaceutical, Inc.Rexulti$119$105,90760 claims
AbbVieVraylar$402$96,57764 claims
Johnson & JohnsonInvega Sustenna$86$49,74313 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 565 psychiatric/mental health providers in Missouri.

Other psychiatric/mental health in Saint Joseph

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →